Xcelience provides the company with specialized clinical trial manufacturing and supply capabilities for a broad range of solid dosage forms Powdersize brings micronization capabilities that augment ...

Morristown, N.J. – April 28, 2014 – Capsugel today announced an agreement with Chiasma, Inc., wherein Capsugel's Dosage Form Solutions (DFS) business unit is scaling up manufacturing for the only ...

REUTERS - Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and ...

NEW YORK -- Pfizer Inc. said Monday it will sell its Capsugel capsule-making business to private equity firm Kohlberg Kravis Robert & Co. for $2.38 billion in cash. In October, Pfizer said it would ...

Lonza Group, a Swiss chemicals and biotechnology company, will acquire Capsugel for $5.5 billion, reports Reuters. Here are four things to know about the deal. 1. Capsugel, based in Morristown, N.J., ...

Swiss pharmaceutical manufacturer Lonza Group is in advanced talks to acquire Capsugel, a U.S. maker of capsule products and other drug delivery systems, for more than $5 billion, according to people ...

Capsugel plans to acquire Bend Research to enhance its bioavailability-enhancement capabilities. Seeking to build its bioavailability-enhancement capabilities, Capsugel, a provider of capsules and ...

I was going to title this post "Big or Small We Track Them All" but on second thought it seemed too wordy and just a little bit confusing. Pharmaceutical giant Pfizer (PFE) announced today that it is ...

Capsugel adds clinical trial and commercial manufacturing, as well as particle engineering services with two acquisitions. In the latest development in a busy year of mergers and acquisitions in the ...